Human Immunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research (DIR), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Clinical Genomics Program, DIR, NIAID, NIH, Bethesda, MD, USA.
Science. 2024 Sep 20;385(6715):eadd8947. doi: 10.1126/science.add8947.
Humans with monogenic inborn errors responsible for extreme disease phenotypes can reveal essential physiological pathways. We investigated germline mutations in , which encodes G, a key component in heterotrimeric G protein signal transduction usually thought to regulate adenylyl cyclase-mediated cyclic adenosine monophosphate (cAMP) production. Patients with activating G mutations had clinical presentations that included impaired immunity. Mutant G impaired cell migration and augmented responses to T cell receptor (TCR) stimulation. We found that mutant G influenced TCR signaling by sequestering the guanosine triphosphatase (GTPase)-activating protein RASA2, thereby promoting RAS activation and increasing downstream extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K)-AKT S6 signaling to drive cellular growth and proliferation.
具有单基因先天错误导致极端疾病表型的人类可以揭示重要的生理途径。我们研究了编码 G 的基因突变,G 是三聚体 G 蛋白信号转导中的关键组成部分,通常被认为调节腺苷酸环化酶介导的环腺苷酸 (cAMP) 产生。具有激活 G 突变的患者具有包括免疫受损在内的临床表现。突变 G 损害细胞迁移并增强对 T 细胞受体 (TCR) 刺激的反应。我们发现突变 G 通过隔离鸟苷三磷酸酶 (GTPase) 激活蛋白 RASA2 来影响 TCR 信号转导,从而促进 RAS 激活并增加下游细胞外信号调节激酶 (ERK)/丝裂原活化蛋白激酶 (MAPK) 和磷酸肌醇 3-激酶 (PI3K)-AKT S6 信号传导,以驱动细胞生长和增殖。